MARKET

ABIO

ABIO

Arca Biopharma Inc
NASDAQ
1.830
+0.010
+0.55%
Closed 16:00 12/01 EST
OPEN
1.820
PREV CLOSE
1.820
HIGH
1.875
LOW
1.815
VOLUME
19.10K
TURNOVER
0
52 WEEK HIGH
2.700
52 WEEK LOW
1.735
MARKET CAP
26.37M
P/E (TTM)
-4.8618
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ABIO last week (1120-1124)?
Weekly Report · 6d ago
Weekly Report: what happened at ABIO last week (1113-1117)?
Weekly Report · 11/20 12:19
Weekly Report: what happened at ABIO last week (1106-1110)?
Weekly Report · 11/13 12:09
Weekly Report: what happened at ABIO last week (1030-1103)?
Weekly Report · 11/06 12:18
Weekly Report: what happened at ABIO last week (1023-1027)?
Weekly Report · 10/30 12:43
Weekly Report: what happened at ABIO last week (1016-1020)?
Weekly Report · 10/23 12:26
Arca Biopharma Inc: Quarterly report
Press release · 10/18 21:09
Arca Biopharma Inc: Current report
Press release · 10/18 21:09
More
About ABIO
ARCA biopharma, Inc. is a clinical stage biopharmaceutical company engaged in the development and commercialization of targeted therapies for cardiovascular diseases. The Company's lead product candidate is Gencaro (bucindolol hydrochloride) for the treatment of atrial fibrillation (AF), in patients with chronic heart failure (HF). Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy. Gencaro is a pharmacogenetically-targeted beta-adrenergic receptor antagonist with mild vasodilator properties that the Company is developing for the treatment of AF in patients with heart failure. The Company's Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), is a protein therapeutic in clinical development as a potential treatment for patients with COVID-19. The rNAPc2 is in a phase IIb clinical trial as a potential treatment for patients hospitalized with COVID-19.

Webull offers Arca Biopharma Inc stock information, including NASDAQ: ABIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ABIO stock methods without spending real money on the virtual paper trading platform.